ADHD Reimagined: New Research Urges Thai Readers to Reconsider Diagnosis and Treatment
A wave of recent studies is reshaping how we think about ADHD. Researchers question whether ADHD is a fixed, lifetime brain disorder and whether the traditional medical model serves everyone it intends to help. With rising global diagnosis rates and more stimulant prescriptions, including in Thailand, the conversation matters for clinicians, families, and students alike.
ADHD has long been described as a chronic neurodevelopmental condition marked by inattention, hyperactivity, and impulsivity that disrupt daily life. For decades, stimulant medications such as methylphenidate and amphetamine have been widely used, grounded in the belief that they correct a biological imbalance. Yet prominent voices in medicine warn that current science does not fully align with real-world experiences of patients, families, and classrooms in Thailand and beyond.